贝伐珠单抗与雷珠单抗治疗糖尿病黄斑水肿(BRDME)研究中光学相干断层扫描特征的预测价值
该研究为前瞻性、6个月、多中心随机对照试验的事后分析,纳入119例接受玻璃体腔注射贝伐珠单抗或雷珠单抗的糖尿病黄斑水肿患者,评估基线视网膜形态学参数与最佳矫正视力及黄斑中心亚区厚度变化的关联。结果显示基线浆液性视网膜脱离与第3个月和第6个月最佳矫正视力字母评分显著改善相关,而视网膜内层结构紊乱与第3个月和第6个月最佳矫正视力字母评分较低相关。
要点
- 基线存在浆液性视网膜脱离与第3个月和第6个月最佳矫正视力字母评分显著改善相关。
- 基线存在视网膜内层结构紊乱与第3个月和第6个月最佳矫正视力字母评分较低相关。
- 浆液性视网膜脱离和视网膜内层结构紊乱与抗血管内皮生长因子治疗的不同反应相关。
核心结论
- 本研究发现浆液性视网膜脱离和视网膜内层结构紊乱与糖尿病黄斑水肿患者对抗血管内皮生长因子治疗的不同反应相关。
研究设计与样本
- 前瞻性、6个月、多中心、随机对照试验的事后分析,共纳入119例接受玻璃体腔注射贝伐珠单抗或雷珠单抗的糖尿病黄斑水肿患者。
主要发现
- 基线存在浆液性视网膜脱离与第3个月最佳矫正视力字母评分显著改善相关(P < 0.001)。
- 基线存在浆液性视网膜脱离与第6个月最佳矫正视力字母评分显著改善相关(P = 0.01)。
- 基线存在视网膜内层结构紊乱与第3个月最佳矫正视力字母评分较低相关(P < 0.05)。
- 基线存在视网膜内层结构紊乱与第6个月最佳矫正视力字母评分较低相关(P = 0.01)。
关键数值与推荐
- 基于核心研究方案,在6个月期间每次强制月度注射前获取最佳矫正视力和黄斑中心亚区厚度。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To establish the predictive value of specific optical coherence tomography retinal features on visual outcomes and retinal thickness during anti-vascular endothelial growth factor treatment in patients with diabetic macular edema. METHODS: Post hoc analysis of compound data of a prospective, 6-month, multicenter, randomized controlled trial of 119 patients with diabetic macular edema receiving either intravitreal bevacizumab or ranibizumab were analyzed to assess the associations between baseline retinal morphologic parameters and change in best-corrected visual acuity and central subfield thickness. Based on the study protocol of the core study, best-corrected visual acuity and central subfield thickness were obtained before each mandatory monthly injection during 6 months. RESULTS: The presence of serous retinal detachment at baseline was associated with significant improvement in best-corrected visual acuity letter score at Month 3 and Month 6 (P < 0.001 and P = 0.01, respectively). In addition, the presence of disorganization of retinal inner layers was associated with lower best-corrected visual acuity letter score at Month 3 and Month 6 (P < 0.05 and P = 0.01, respectively). CONCLUSION: This study found that serous retinal detachment and disorganization of retinal inner layers were associated with different treatment responses to anti-vascular endothelial growth factor therapy in patients with diabetic macular edema.
引用
- Fickweiler W, Schauwvlieghe AME, Schlingemann RO, et al. PREDICTIVE VALUE OF OPTICAL COHERENCE TOMOGRAPHIC FEATURES IN THE BEVACIZUMAB AND RANIBIZUMAB IN PATIENTS WITH DIABETIC MACULAR EDEMA (BRDME) STUDY. Retina. 2018. PMID: 28406860. doi:10.1097/IAE.0000000000001626
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。